Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TRANSADO hormonal treatment trial in adolescents with gender dysphoria
2024-513250-30-00Phase 3Authorised
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of estradiol and testosterone in gender dysphoria (GD) (2 arms), sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoint: Children's Global Assessment Scale. Planned start Jun 2024; status: authorised.
02
Drugs
estradioltestosterone
03
Conditions
gender dysphoria (GD)
Beyond the preview
Go deeper on 2024-513250-30-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-513250-30-00.